STOCK TITAN
  1. Home
  2. ACRX

ACRX (ACRX) Stock Price, News & Analysis

ACRX NASDAQ

Company Description

ACRX (NASDAQ: ACRX) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for ACRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
+7.50%

AcelRx Announces Rebranding With Name Change to Talphera, Inc.

-9.01%

AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States

-11.34%

AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update

earnings
+1.81%

AcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study

conferences clinical trial
-3.82%

AcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023

conferences earnings date
+4.27%

AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study

ACRX has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, clinical trial, earnings date, private placement. View all ACRX news →

SEC Filings

View All

No SEC filings available for ACRX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ACRX Company Profile & Sector Positioning

ACRX (ACRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.